Am J Psychiatry 161:1079-1083, June 2004
© 2004 American Psychiatric Association
A Randomized, Placebo-Controlled Trial of Citalopram for the Treatment of Major Depression in Children and Adolescents
Karen Dineen Wagner, M.D., Ph.D.,
Adelaide S. Robb, M.D.,
Robert L. Findling, M.D.,
Jianqing Jin, Ph.D.,
Marcelo M. Gutierrez, Ph.D., and
William E. Heydorn, Ph.D.
OBJECTIVE: Open-label trials with the selective serotonin reuptake inhibitor citalopram suggest that this agent is effective and safe for the treatment of depressive symptoms in children and adolescents. The current study investigated the efficacy and safety of citalopram compared with placebo in the treatment of pediatric patients with major depression. METHOD: An 8-week, randomized, double-blind, placebo-controlled study compared the safety and efficacy of citalopram with placebo in the treatment of children (ages 7–11) and adolescents (ages 12–17) with major depressive disorder. Diagnosis was established with the Schedule for Affective Disorders and Schizophrenia for School-Age Children—Present and Lifetime Version. Patients (N=174) were treated initially with placebo or 20 mg/day of citalopram, with an option to increase the dose to 40 mg/day at week 4 if clinically indicated. The primary outcome measure was score on the Children’s Depression Rating Scale—Revised; the response criterion was defined as a score of  28. RESULTS: The overall mean citalopram dose was approximately 24 mg/day. Mean Children’s Depression Rating Scale—Revised scores decreased significantly more from baseline in the citalopram treatment group than in the placebo treatment group, beginning at week 1 and continuing at every observation point to the end of the study (effect size=2.9). The difference in response rate at week 8 between placebo (24%) and citalopram (36%) also was statistically significant. Citalopram treatment was well tolerated. Rates of discontinuation due to adverse events were comparable in the placebo and citalopram groups (5.9% versus 5.6%, respectively). Rhinitis, nausea, and abdominal pain were the only adverse events to occur with a frequency exceeding 10% in either treatment group. CONCLUSIONS: In this population of children and adolescents, treatment with citalopram reduced depressive symptoms to a significantly greater extent than placebo treatment and was well tolerated.
This article has been cited by other articles:
|
|
|
|
 
S. H. Busch and C. L. Barry
Pediatric Antidepressant Use After The Black-Box Warning
Health Aff.,
May 1, 2009;
28(3):
724 - 733.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Williams, E. A. O'Connor, M. Eder, and E. P. Whitlock
Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review for the US Preventive Services Task Force
Pediatrics,
April 1, 2009;
123(4):
e716 - e735.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Bridge, B. Birmaher, S. Iyengar, R. P. Barbe, and D. A. Brent
Placebo Response in Randomized Controlled Trials of Antidepressants for Pediatric Major Depressive Disorder
Am J Psychiatry,
January 1, 2009;
166(1):
42 - 49.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Tsapakis*, F. Soldani*, L. Tondo, and R. J. Baldessarini
Efficacy of antidepressants in juvenile depression: meta-analysis
The British Journal of Psychiatry,
July 1, 2008;
193(1):
10 - 17.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B Dubicka and P Wilkinson
Evidence-based treatment of adolescent major depression
Evid. Based Ment. Health,
November 1, 2007;
10(4):
100 - 102.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H. Cheung, R. A. Zuckerbrot, P. S. Jensen, K. Ghalib, D. Laraque, R. E.K. Stein, and and the GLAD-PC Steering Group
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and Ongoing Management
Pediatrics,
November 1, 2007;
120(5):
e1313 - e1326.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Bridge, S. Iyengar, C. B. Salary, R. P. Barbe, B. Birmaher, H. A. Pincus, L. Ren, and D. A. Brent
Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment: A Meta-analysis of Randomized Controlled Trials
JAMA,
April 18, 2007;
297(15):
1683 - 1696.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. DUBICKA, S. HADLEY, and C. ROBERTS
Suicidal behaviour in youths with depression treated with new-generation antidepressants: Meta-analysis
The British Journal of Psychiatry,
November 1, 2006;
189(5):
393 - 398.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Dopheide
Recognizing and treating depression in children and adolescents
Am. J. Health Syst. Pharm.,
February 1, 2006;
63(3):
233 - 243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H. Cheung, G. J. Emslie, and T. L. Mayes
The use of antidepressants to treat depression in children and adolescents
Can. Med. Assoc. J.,
January 17, 2006;
174(2):
193 - 200.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. MARTIN, W. S. GILLIAM, J. Q. BOSTIC, and J. M. REY
Child Psychopharmacology, Effect Sizes, and the Big Bang
Am J Psychiatry,
April 1, 2005;
162(4):
817 - 817.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Other articles noted
Evid. Based Ment. Health,
February 1, 2005;
8(1):
3 - 4.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Asarnow, L. H. Jaycox, N. Duan, A. P. LaBorde, M. M. Rea, P. Murray, M. Anderson, C. Landon, L. Tang, and K. B. Wells
Effectiveness of a Quality Improvement Intervention for Adolescent Depression in Primary Care Clinics: A Randomized Controlled Trial
JAMA,
January 19, 2005;
293(3):
311 - 319.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M L Murray, C S de Vries, and I C K Wong
A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database
Arch. Dis. Child.,
December 1, 2004;
89(12):
1098 - 1102.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Other articles noted
Evid. Based Med.,
September 1, 2004;
9(5):
e5 - e5.
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2004
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
